The present state of success in kidney transplantation, including its benefits to patients with end-stage renal failure, was achieved through relentless research, both in experimental animal models and human volunteers. Kidney transplantation has evolved during the past century thanks to various milestones in surgical techniques, immunology, immunosuppressive drugs, expansion of donor sources, organ preservation, transplant against immunological barriers (ABO blood group-incompatible and positive crossmatch transplants), and research on induction of tolerance, xenotransplants, and stem cell technology. Despite significant improvements in graft and patient survival, several issues still must be addressed to reduce the growing number of patients with kidney failure waiting to receive organs. This article provides an up-to-date review of the milestones in the history of kidney transplantation and highlights strategies to resolve current problems faced by patients and the transplant community.
Get full access to this article
View all access options for this article.
References
1.
ShresthaAShresthaABasarab-HorwathCMcKaneWShresthaBRafteryA. Quality of life following live donor renal transplantation: A single centre experienceAnn Transplant.2010;15(2):5–10.
2.
Kidney Transplant Activity in 2012 in 84 Countries. World Health Organisation.http://issuu.com/o-n-t/docs/2012ad. Accessed August 25, 2014.
3.
ShresthaBM. Strategies for reducing the renal transplant waiting list: A reviewExp Clin Transplant.2009;7(3):173–179.
4.
KahanBD. Ganesha: The primeval Hindu xenograftTransplant Proc.1989;21(3suppl 1):1–8.
5.
BhishagratnaKKL. Sushruta Samhita: An English Translation of the Susruta Samhita.BhishagratnaKL, ed. 1907.
6.
HunterJPalmerJF. The Complete Works of John Hunter, F.R.S.Philadelphia, PA: Haswell, Harrington, and Haswell; 1841:57.
7.
CarrelA. La technique operatoire des anastomosis vasculaires, et la transplantation des visceresLyon Med.1902;98:859–864.
8.
JaboulayM. Greffew de reinsau pli du coude par soudures artereilles et veinusesLyon Med.1906;107:575.
HamiltonDNReidWA. Yu. Yu. Voronoy and the first human kidney allograftSurg Gynecol Obstet.1984;159(3):289–294.
11.
GuildWRHarrisonJHMerrillJPMurrayJ. Successful homotransplantation of the kidney in an identical twinTrans Am Clin Climatol Assoc.1955–1956;67:167–173.
12.
HumeDMMerrilJPMillerBFThornGW. Experiences with renal homotransplantation in man modified recipientsJ Clin Invest.1955;34(2):327–382.
13.
Brain stem death and organ donation. BMJ.1989;299(6712): 1282–1286.
14.
SimpsonA. Organ transplants. Brain stem deathNurs Times.1987;83(8):41–42.
15.
DaemenJWKootstraGWijnenRMYinMHeinemanE. Nonheart-beating donors: The Maastricht experienceClin Transpl.1994:303–316.
16.
FieuxFLosserMRBourgeoisE. Kidney retrieval after sudden out of hospital refractory cardiac arrest: A cohort of uncontrolled non heart beating donorsCrit Care.2009;13(4):R141.
17.
HashianiAARajaeefardAHasanzadehJ. Ten-year graft survival of deceased-donor kidney transplantation: A single-center experienceRen Fail.2010;32(4):440–447.
18.
MassonDHeftyT. A technique for the transplantation of 2 adult cadaver kidney grafts into 1 recipientJ Urol.1998;160(5):1779–1780.
19.
EkserBFurianLBroggiatoA. Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: Experience of 100 patientsAm J Transplant.2010;10(9):2000–2007. doi: 10.1111/j.1600-6143.2010.03188.x.
20.
RatnerLECiseckLJMooreRGCigarroaFGKaufmanHSKavoussiLR. Laparoscopic live donor nephrectomyTransplantation.1995;60(9):1047–1049.
21.
WolfJSJrTchetgenMBMerionRM. Hand-assisted laparoscopic live donor nephrectomyUrology.1998;52(5):885–887.
22.
GillISCanesDAronM. Single port transumbilical (E-NOTES) donor nephrectomyJ Urol.2008;180(2):637–641;discussion 641.
23.
RenoultEHubertJLadriereM. Robot-assisted laparoscopic and open live-donor nephrectomy: A comparison of donor morbidity and early renal allograft outcomesNephrol Dial Transplant.2006;21(2):472–477.
24.
BelzerFOSouthardJH. Principles of solid-organ preservation by cold storageTransplantation.1988;45(4):673–676.
25.
PloegRJvan BockelJHLangendijkPT. Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study GroupLancet.1992;340(8812):129–137.
26.
BelzerFOAshbyBSGulyassyPFPowellM. Successful seventeen-hour preservation and transplantation of human-cadaver kidneyN Engl J Med.1968;278(11):608–610.
27.
O'CallaghanJMMorganRDKnightSRMorrisPJ. Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomesBr J Surg.2013;100(8):991–1001.
28.
KellyWDLilleheiRCMerkelFKIdezukiYGoetzFC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathySurgery.1967;61(6):827–837.
29.
GruessnerACSutherlandDEGruessnerRW. Long-term outcome after pancreas transplantationCurr Opin Organ Transplant.2012;17(1):100–105.
30.
MedawarPB. The behaviour and fate of skin autografts and skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research CouncilJ Anat.1944;78(pt 5):176–199.
31.
MedawarPB. A second study of the behaviour and fate of skin homografts in rabbits: A Report to the War Wounds Committee of the Medical Research CouncilJ Anat.1945;79(pt 4): 157–176.
32.
KohlerGHengartnerHShulmanMJ. Immunoglobulin production by lymphocyte hybridomasEur J Immunol.1978;8(2):82–88.
33.
Kissmeyer-NielsenFOlsenSPetersenVPFjeldborgO. Hyperacute rejection of kidney allografts, associated with preexisting humoral antibodies against donor cellsLancet.1966;2(7465):662–665.
34.
LaffertyKJCunninghamAJ. A new analysis of allogeneic interactionsAust J Exp Biol Med Sci.1975;53(1):27–42.
35.
KleinJFigueroaF. Polymorphism of the mouse H-2 lociImmunol Rev.1981;60:23–57.
36.
DallmanMJMasonDW. Induction of Ia antigens on murine epidermal cells during the rejection of skin allograftsTransplantation.1983;36(2):222–224.
37.
ZinkernagelRM. The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1996. Cellular immune recognition and the biological role of major transplantation antigensScand J Immunol.1997;46(5):421–436.
38.
FullerAARodeyGEParhamPFullerTC. Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probesHum Immunol.1990;28(3):306–325.
39.
CroftMDubeyC. Accessory molecule and costimulation requirements for CD4 T cell responseCrit Rev Immunol.1997;17(1):89–118.
40.
HamburgerJ. 11 Attempts at renal homotransplants in man after irradiation of the receiver [in Spanish] Rev Med Chil.1963;91:446–459.
41.
SchwartzRDameshekW. The effects of 6-mercaptopurine on homograft reactionsJ Clin Invest.1960;39:952–958.
42.
CalneRYAlexandreGPMurrayJE. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogsAnn N Y Acad Sci.1962;99:743–761.
43.
ZukoskiCFCallawayJMRheaWGJr. Prolonged acceptance of a canine renal allograft achieved with prednisoloneTransplantation.1965;3:380–386.
44.
LeveyRHMedawarPB. Mechanism of action of antilymphoid antiseraSurg Forum.1966;17:247–249.
45.
StarzlTEMarchioroTLHutchinsonDEPorterKACerilliGJBrettschneiderL. The clinical use of antilymphocyte globulin in renal homotransplantationTransplantation.1967;5(4 suppl):1100–1105.
46.
BorelJF. Ciclosporin and its futureProg Allergy.1986;38:9–18.
47.
KahanBD. Cyclosporine: The agent and its actionsTransplant Proc.1985;17(4suppl 1):5–18.
48.
CalneRYRollesKWhiteDJ. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 liversLancet.1979;2(8151):1033–1036.
49.
CalneRYThiruSMcMasterP. Cyclosporin A in patients receiving renal allografts from cadaver donors. 1978J Am Soc Nephrol.1998;9(9):1751–1756.
50.
CosimiABBurtonRCColvinRB. Treatment of acute renal allograft rejection with OKT3 monoclonal antibodyTransplantation.1981;32(6):535–539.
51.
FungJJ. Tacrolimus and transplantation: A decade in reviewTransplantation.2004;77(9 suppl):S41–43.
52.
MayerADDmitrewskiJSquiffletJP. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study GroupTransplantation.1997;64(3):436–443.
53.
WebsterACWoodroffeRCTaylorRSChapmanJRCraigJC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial dataBMJ.2005;331(7520):810.
54.
MathewTH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study GroupTransplantation.1998;65(11):1450–1454.
55.
KahanBD. Sirolimus: A ten-year perspectiveTransplant Proc.2004;36(1):71–75.
KirschBMHaidingerMZeydaM. Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipientsTranspl Immunol.2006;16(3–4):254–257.
58.
TydenGKumlienGGenbergHSandbergJLundgrenTFehrmanI. ABO-incompatible kidney transplantation and rituximabTransplant Proc.2005;37(8):3286–3287.
59.
BuddeKSchmouderRLBrunkhorstR. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patientsJ Am Soc Nephrol.2002;13(4):1073–1083.
60.
DurrbachAFrancoisHBeaudreuilSJacquetACharpentierB. Advances in immunosuppression for renal transplantationNat Rev Nephrol.2010;6(3):160–167.
61.
ChungBHLeeJYKangSH. Comparison of patient outcome according to renal replacement modality after renal allograft failureRen Fail.2011;33(3):261–268.
62.
AlexandreGPSquiffletJPDe BruyereM. Present experiences in a series of 26 ABO-incompatible living donor renal allograftsTransplant Proc.1987;19(6):4538–4542.
63.
SonnendayCJWarrenDSCooperM. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomyAm J Transplant.2004;4(8):1315–1322.
64.
WarrenDSZacharyAASonnendayCJ. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriersAm J Transplant.2004; 4(4):561–568.
65.
IshidaHTanabeKTomaHAkibaT. Therapeutic apheresis therapy for ABO-incompatible renal transplantationsTher Apher Dial.2003;7(6):520–528.
66.
BryanCFNelsonPWShieldCF3rd. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rateClin Transpl.2004:127–133.
67.
MontgomeryRAZacharyAA. Transplanting patients with a positive donor-specific crossmatch: A single center's perspectivePediatr Transplant.2004;8(6):535–542.
68.
FreitasMC. Kidney transplantation in the US: An analysis of the OPTN/UNOS registryClin Transpl.2011:1–16.
69.
HariharanSJohnsonCPBresnahanBATarantoSEMcIntoshMJStableinD. Improved graft survival after renal transplantation in the United States, 1988 to 1996N Engl J Med.2000;342(9):605–612.
70.
PascualMTheruvathTKawaiTTolkoff-RubinNCosimiAB. Strategies to improve long-term outcomes after renal transplantationN Engl J Med.2002;346(8):580–590.
71.
ShresthaBMHaylorJL. Factors influencing long-term outcomes following renal transplantation: A reviewJNMA J Nepal Med Assoc.2007;46(167):136–142.
72.
PilatNWekerleT. Transplantation tolerance through mixed chimerismNat Rev Nephrol.2010;6(10):594–605.
73.
BillinghamREBrentLMedawarPB. Actively acquired tolerance of foreign cellsNature.1953;172(4379):603–606.
74.
TerzicAEdwardsBSMcKeeKCNelsonTJ. Regenerative medicine: A reality of stem cell technologyMinn Med.2011;94(5):44–47.
75.
VincentiFLarsenCDurrbachA. Costimulation blockade with belatacept in renal transplantationN Engl J Med.2005;353(8):770–781.
76.
GoodAHCooperDKMalcolmAJ. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humansTransplant Proc.1992;24(2):559–562.
77.
CooperDKGoodAHKorenE. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in manTranspl Immunol.1993;1(3):198–205.
78.
CozziEWhiteDJ. The generation of transgenic pigs as potential organ donors for humansNat Med.1995;1(9):964–966.
ZhaoYFishmanJASergioJJ. Immune restoration by fetal pig thymus grafts in T cell-depleted, thymectomized miceJ Immunol.1997;158(4):1641–1649.
83.
HackingSAKachouieNNLeeWGKhademhosseiniA. Future approaches to organ regeneration: Microscale environments, stem cell engineering, and self-assembly of living tissuesStud Health Technol Inform.2009;149:214–235.
